ETF Fundamental Report for IWM

Validea's fundamental analysis of the iShares Russell 2000 ETF (IWM) reveals a small-cap value ETF with its largest sector allocation in Services and industry allocation in Biotechnology & Drugs. The ETF exhibits moderate exposure to value (score of 57), but low exposure to momentum (25), quality (8), and low volatility (13).

Analysis

Validea's fundamental report on the iShares Russell 2000 ETF (IWM) characterizes it as a Small-Cap Value ETF, with its largest sector exposure in Services and the most significant industry concentration in Biotechnology & Drugs. The ETF's factor analysis reveals a moderate exposure to the value factor, with a score of 57 out of a possible 99. However, IWM scores considerably lower on other key investment factors: momentum is at 25, quality is notably low at 8, and low volatility stands at 13. This profile suggests that while IWM aligns somewhat with its value mandate, its underlying holdings currently exhibit weak quality characteristics, lack strong recent price momentum, and possess a higher volatility profile, which may be typical for small-cap equities but is underscored by these specific low factor scores.

Key Decisions for Investors

• Investors should acknowledge that IWM's very low quality score (8) and low volatility score (13) indicate a portfolio potentially carrying higher risk and comprising companies with weaker financial fundamentals, despite its classification as a value ETF.
• Considering the moderate value score of 57 and a low momentum score of 25, IWM might be appropriate for investors specifically seeking small-cap value exposure who are willing to accept potential underperformance in momentum-driven market phases and are prepared for the volatility associated with lower-quality small-cap stocks.
• The significant allocation to the Biotechnology & Drugs industry, when combined with the ETF's overall factor profile, warrants careful assessment of sector-specific risks and thorough consideration of how IWM complements an investor's existing diversified portfolio, especially for those with lower risk tolerance.